Barbro Eriksson

15.4k total citations · 2 hit papers
151 papers, 10.6k citations indexed

About

Barbro Eriksson is a scholar working on Epidemiology, Neurology and Oncology. According to data from OpenAlex, Barbro Eriksson has authored 151 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Epidemiology, 80 papers in Neurology and 79 papers in Oncology. Recurrent topics in Barbro Eriksson's work include Neuroendocrine Tumor Research Advances (116 papers), Neuroblastoma Research and Treatments (80 papers) and Lung Cancer Research Studies (58 papers). Barbro Eriksson is often cited by papers focused on Neuroendocrine Tumor Research Advances (116 papers), Neuroblastoma Research and Treatments (80 papers) and Lung Cancer Research Studies (58 papers). Barbro Eriksson collaborates with scholars based in Sweden, Italy and Germany. Barbro Eriksson's co-authors include Kjell Öberg, Britt Skogseid, Anders Sundin, Eva Tiensuu Janson, Mats Stridsberg, Donald Granberg, Günter Klöppel, Guido Rindi, Massimo Falconi and Göran Åkerström and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Barbro Eriksson

150 papers receiving 10.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

2016 911 citations Barbro Eriksson, Martyn Caplin et al. Neuroendocrinology profile →
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

2017 303 citations Anders Sundin, Rudolf Arnold et al. Neuroendocrinology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbro Eriksson Sweden	57	8.8k	7.7k	6.2k	1.1k	1.0k	151	10.6k
Anders Sundin Sweden	51	6.1k 0.7×	5.5k 0.7×	4.1k 0.7×	1.5k 1.3×	1.9k 1.9×	216	9.3k
Paola Tomassetti Italy	37	5.2k 0.6×	4.9k 0.6×	3.5k 0.6×	900 0.8×	326 0.3×	117	6.6k
Dieter Hörsch Germany	31	4.4k 0.5×	4.1k 0.5×	3.1k 0.5×	967 0.8×	432 0.4×	96	7.0k
Edward M. Wolin United States	34	6.0k 0.7×	5.7k 0.7×	4.4k 0.7×	395 0.3×	258 0.3×	135	7.3k
Willem H. Bakker Netherlands	43	5.5k 0.6×	4.3k 0.6×	3.6k 0.6×	513 0.5×	3.0k 3.0×	83	8.1k
Damian Wild Switzerland	36	2.9k 0.3×	2.6k 0.3×	1.5k 0.2×	607 0.5×	1.7k 1.7×	127	4.6k
Stanislas Pauwels Belgium	29	2.1k 0.2×	1.8k 0.2×	1.2k 0.2×	423 0.4×	1.3k 1.3×	76	3.5k
Enrique Grande Spain	35	1.4k 0.2×	2.5k 0.3×	966 0.2×	831 0.7×	202 0.2×	286	4.6k
Klaus Kaserer Austria	40	1.4k 0.2×	1.3k 0.2×	520 0.1×	1.3k 1.2×	450 0.4×	108	4.4k
Alexander Haug Austria	42	1.6k 0.2×	1.8k 0.2×	1.0k 0.2×	774 0.7×	2.0k 2.0×	187	4.9k

Countries citing papers authored by Barbro Eriksson

Since Specialization

Citations

This map shows the geographic impact of Barbro Eriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbro Eriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbro Eriksson more than expected).

Fields of papers citing papers by Barbro Eriksson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbro Eriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbro Eriksson. The network helps show where Barbro Eriksson may publish in the future.

Co-authorship network of co-authors of Barbro Eriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Barbro Eriksson. A scholar is included among the top collaborators of Barbro Eriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbro Eriksson. Barbro Eriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Botling, Johan, Britt Skogseid, Barbro Eriksson, et al.. (2025). The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study. Journal of Neuroendocrinology. 37(8). e70040–e70040. 2 indexed citations

García‐Carbonero, Rocio, Anja Rinke, Juan W. Valle, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Chemotherapy. Neuroendocrinology. 105(3). 281–294. 82 indexed citations

Pavel, Marianne, Juan W. Valle, Barbro Eriksson, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. Neuroendocrinology. 105(3). 266–280. 110 indexed citations

Sundin, Anders, Rudolf Arnold, Éric Baudin, et al.. (2017). ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging. Neuroendocrinology. 105(3). 212–244. 303 indexed citations breakdown →

Eriksson, Olof, Ulrika Rosenström, Ram Kumar Selvaraju, Barbro Eriksson, & Irina Velikyan. (2017). Species differences in pancreatic binding of DO3A-VS-Cys40-Exendin4. Acta Diabetologica. 54(11). 1039–1045. 26 indexed citations

Velikyan, Irina, Ram Kumar Selvaraju, Daniel Espes, et al.. (2015). Dosimetry of [Ga-68]Ga-DO3A-VS-Cys(40)-Exendin-4 in rodents, pigs, non-human primates and human. Journal of Labelled Compounds and Radiopharmaceuticals. 58. 1 indexed citations

Wolin, Edward M., Barbara Jarząb, Barbro Eriksson, et al.. (2015). Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues. Drug Design Development and Therapy. 9. 5075–5075. 150 indexed citations

Wolin, Edward M., Barbara Jarząb, Barbro Eriksson, et al.. (2014). A Multicenter, Randomized, Blinded, Phase 3 Study of Pasireotide LAR vs Octreotide LAR in Patients with Metastatic Neuroendocrine Tumors (NET) with Disease-Related Symptoms Inadequately Controlled by Somatostatin Analogs. Pancreas. 43(3). 508–508. 2 indexed citations

Lubberink, Mark, Mattias Sandström, Jens Christian Hedemann Sørensen, et al.. (2013). Tracer kinetic analysis of 68Ga-DOTATATE and 68Ga-DOTATOC in neuroendocrine tumours. 54(6). 200–200. 2 indexed citations

10.

Kianmanesh, Réza, Philippe Ruszniewski, Guido Rindi, et al.. (2010). ENETS Consensus Guidelines for the Management of Peritoneal Carcinomatosis from Neuroendocrine Tumors. Neuroendocrinology. 91(4). 333–340. 45 indexed citations

11.

Eriksson, Barbro, Mesut Akarsu, Hatice Durak, et al.. (2009). A patient with nonfunctional pancreatic neuroendocrine tumor and incidental metachronous colon carcinoma detected by positron emission tomography: Case report. The Turkish Journal of Gastroenterology. 20(3). 214–219. 4 indexed citations

12.

Lendvai, Gábor, Irina Velikyan, Sergio Estrada, et al.. (2008). Biodistribution of ⁶⁸ Ga-Labeled LNA–DNA Mixmer Antisense Oligonucleotides for Rat Chromogranin-A. Oligonucleotides. 18(1). 33–49. 23 indexed citations

13.

Öberg, Kjell & Barbro Eriksson. (2005). Endocrine tumours of the pancreas. Best Practice & Research Clinical Gastroenterology. 19(5). 753–781. 382 indexed citations

14.

Stridsberg, Mats, et al.. (2004). A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B. Regulatory Peptides. 125(1-3). 193–199. 54 indexed citations

15.

Wu, Feng, Ulrika Yngve, Frank Leigh Lu, et al.. (2000). Distribution of 76Br-labeled antisense oligonucleotides of different length determined ex vivo in rats. European Journal of Pharmaceutical Sciences. 10(3). 179–186. 27 indexed citations

16.

Bergström, Mats, et al.. (1996). Modulation of organ uptake of 11C-5-hydroxytryptophan.. 12(6). 477–485. 7 indexed citations

17.

Bergström, Mats, Marcela Márquez, Robert Moulder, et al.. (1996). Catechol-O-Methyltransferase Inhibition Increases the Uptake of¹¹C-3-(3,4-Dihydroxyphenyl)-L-Alanine in the Rat Pancreas. Scandinavian Journal of Gastroenterology. 31(12). 1216–1222. 3 indexed citations

18.

Eriksson, Barbro, Anders Lilja, Håkan Åhlström, et al.. (1994). Positron‐Emission Tomography as a Radiological Technique in Neuroendocrine Gastrointestinal Tumors. Annals of the New York Academy of Sciences. 733(1). 446–452. 8 indexed citations

19.

Eriksson, Barbro, Mats Bergström, Anders Lilja, et al.. (1993). Positron Emission Tomography (PET) in Neuroendocrine Gastrointestinal Tumors. Acta Oncologica. 32(2). 189–196. 44 indexed citations

20.

Eriksson, Barbro, Henrik Arnberg, Urban Hellman, et al.. (1989). Chromogranins — New Sensitive Markers for Neuroendocrine Tumors. Acta Oncologica. 28(3). 325–329. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact